Literature DB >> 17693546

Salt-sensing mechanisms in blood pressure regulation and hypertension.

Sergei N Orlov1, Alexander A Mongin.   

Abstract

High salt consumption contributes to the development of hypertension and is considered an independent risk factor for vascular remodeling, cardiac hypertrophy, and stroke incidence. In this review, we discuss the molecular origins of primary sensors involved in the phenomenon of salt sensitivity. Based on the analysis of literature data, we conclude that the kidneys and central nervous system (CNS) are two major sites for salt sensing via several distinct mechanisms: 1) [Cl(-)] sensing in renal tubular fluids, primarily by Na(+)-K(+)-Cl(-) cotransporter (NKCC) isoforms NKCC2B and NKCC2A, whose expression is mainly limited to macula densa cells; 2) [Na(+)] sensing in cerebrospinal fluid (CSF) by a novel isoform of Na(+) channels, Na(x), expressed in subfornical organs; 3) sensing of CSF osmolality by mechanosensitive, nonselective cation channels (transient receptor potential vanilloid type 1 channels), expressed in neuronal cells of supraoptic and paraventricular nuclei; and 4) osmolarity sensing by volume-regulated anion channels in glial cells of supraoptic and paraventricular nuclei. Such multiplicity of salt-sensing mechanisms likely explains the differential effects of Na(+) and Cl(-) loading on the long-term maintenance of elevated blood pressure that is documented in experimental models of salt-sensitive hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693546     DOI: 10.1152/ajpheart.00325.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  41 in total

1.  SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.

Authors:  Sung-Sen Yang; Yi-Fen Lo; Chin-Chen Wu; Shu-Wha Lin; Chien-Ju Yeh; Pauling Chu; Huey-Kang Sytwu; Shinichi Uchida; Sei Sasaki; Shih-Hua Lin
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

Review 2.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 3.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 4.  Aldosterone in the brain.

Authors:  Joel C Geerling; Arthur D Loewy
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

Review 5.  Endogenous cardiotonic steroids and salt-sensitive hypertension.

Authors:  Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Biochim Biophys Acta       Date:  2010-03-27

6.  Na+ homeostasis by epithelial Na+ channel (ENaC) and Nax channel (Nax): cooperation of ENaC and Nax.

Authors:  Yoshinori Marunaka; Rie Marunaka; Hongxin Sun; Toshiro Yamamoto; Narisato Kanamura; Akiyuki Taruno
Journal:  Ann Transl Med       Date:  2016-10

7.  Salt intake augments hypotensive effects of transient receptor potential vanilloid 4: functional significance and implication.

Authors:  Feng Gao; Dexin Sui; R Michael Garavito; R Mark Worden; Donna H Wang
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

Review 8.  Stress-induced sodium retention and hypertension: a review and hypothesis.

Authors:  Gregory A Harshfield; Yanbin Dong; Gaston K Kapuku; Haidong Zhu; Coral D Hanevold
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

9.  Cerebrospinal fluid sodium rhythms.

Authors:  Michael G Harrington; Ronald M Salomon; Janice M Pogoda; Elena Oborina; Neil Okey; Benjamin Johnson; Dennis Schmidt; Alfred N Fonteh; Nathan F Dalleska
Journal:  Cerebrospinal Fluid Res       Date:  2010-01-20

Review 10.  Apelin/APJ system: a promising therapy target for hypertension.

Authors:  Di Wu; Lu He; Linxi Chen
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.